Noltec
MarketedA Korean-developed new drug for gastric ulcers and reflux oesophagitis.
A pharmaceutical company making Korean-developed new drugs such as the ulcer drug Noltec and the leukaemia drug Supect, as well as over-the-counter medicines and vaccines.
A Korean-developed new drug for gastric ulcers and reflux oesophagitis.
Korean-developed leukaemia drug pursued in China through a joint venture.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.